CD63<sup>+</sup> Cancer‐Associated Fibroblasts Confer Tamoxifen Resistance to Breast Cancer Cells through Exosomal miR‐22
2020 · Advanced Science · 141 citations
https://doi.org/10.1002/advs.202002518
Y
Yingqi Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
176
Papers
3.7K
Citations
32
h-index
89
i10-index
Yingqi Zhang is an academic researcher from The University of Sydney. The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & Immunotherapy and Immune Responses & Peptidase Inhibition and Analysis. The author has an h-index of 32, co-authored 150 publications.
ORCID: 0000-0001-8096-9660Papers by this author
worksLoss of ERα induces amoeboid-like migration of breast cancer cells by downregulating vinculin
2017 · Nature Communications · 71 citations
https://doi.org/10.1038/ncomms14483
A novel peptide (GX1) homing to gastric cancer vasculature inhibits angiogenesis and cooperates with TNF alpha in anti-tumor therapy
2009 · BMC Cell Biology · 60 citations
https://doi.org/10.1186/1471-2121-10-63
FOXP3 inhibits angiogenesis by downregulating VEGF in breast cancer
2018 · Cell Death and Disease · 59 citations
https://doi.org/10.1038/s41419-018-0790-8
CXCL12+ tumor-associated endothelial cells promote immune resistance in hepatocellular carcinoma
2024 · Journal of Hepatology · 44 citations
https://doi.org/10.1016/j.jhep.2024.09.044
DDR2–CYR61–MMP1 Signaling Pathway Promotes Bone Erosion in Rheumatoid Arthritis Through Regulating Migration and Invasion of Fibroblast-Like Synoviocytes
2016 · Journal of Bone and Mineral Research · 31 citations
https://doi.org/10.1002/jbmr.2993
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat